We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angle Plc | LSE:AGL | London | Ordinary Share | GB0034330679 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 29.09% | 17.75 | 17.00 | 18.50 | 18.25 | 15.25 | 16.25 | 7,554,983 | 16:29:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 1.04M | -21.69M | -0.0832 | -2.13 | 46.25M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/5/2024 00:23 | I prefer 698 over 699. The medicine must have worn off | sellsell | |
06/5/2024 00:08 | So much for the extra revenues they have raised thus far, half a year gone and only a few hundred thousand! Way off £6m revenues needed to extend the cash run way to Q2 2025! | bones699 | |
06/5/2024 00:06 | Only news here is cash is running out and a placement is needed!...That's all you need to know! | bones699 | |
05/5/2024 23:54 | https://youtu.be/IV9 | atmysignal | |
05/5/2024 23:50 | I get you. ANG wasn't even on my watch list. I'm happy turning 10k in a few weeks and then back to my main plays. It's all about opportunities. Surely we are here to make money too? I will see what happens on Tuesday and Wednesday and then make a decision | sellsell | |
05/5/2024 23:14 | @bones998…can you let us know what news is due please? Textbook ramping trying to spin up FOMO to rescue their own losses. | adw198 | |
05/5/2024 23:10 | For the traders just be aware a lot more news is actually due aswell as what we have had already and until. They announce the reuskts date I would say more could come that will boost the share price more. Just saying don't sell too soon and the mms will tree shake this a lot | bones698 | |
05/5/2024 23:08 | https://www.thetimes | atmysignal | |
05/5/2024 22:56 | With the Times article and The Mail snippet. This will gap up and run to mid/high 20s first stop. 30s next week likely. Then 50p+Can you not see this has form. | atmysignal | |
05/5/2024 22:14 | Ride the momentum. Are you not here to make money? I only heard about ANG two weeks ago. I bought at 16p. Looking to flip at 22p. Over 10grand in a few weeks. Don't judge me. It's why we are here | sellsell | |
05/5/2024 21:27 | I agree all the press and interest makes this very likely to go up more over the next few sessions. We know this can move big, so hard to know the limit. I suspect the early part of the week will see an RNS stating the date for results, which I’m fairly confident have been delayed to let the AZ news land. As previously stated I wouldn’t be at all surprised if a raise is announced within a few days either side of results. I do enjoy a volatile stock! | adw198 | |
05/5/2024 20:53 | That would be an impressive 4th gap up | atmysignal | |
05/5/2024 20:46 | Tree shake city from the mms no doubt but the press articles and buzz will see this move up throughout the day. If the mms decide to play games the traders will jump on board and trade it up too. Buying the dips. Will be fun for sure | bones698 | |
05/5/2024 20:35 | wouldn't be surprised to see this open 20-21 tbh | spa362 | |
05/5/2024 20:30 | A chance for people to go long Tuesday below 20p | atmysignal | |
05/5/2024 20:09 | 30p Then 50pLikely Triple bear trap gap upsMore news to come | atmysignal | |
05/5/2024 19:41 | There is every reason for this stock to re-rate quite quickly now and market behaviour on Friday suggested that. Still time to get in IMHO but that opportunity may be very time limited. Wouldn't like to say where it might re-rate to in the short term - but 40p upwards would not be out of the question given the significant announcements that have been made (maybe higher if further news) | spa362 | |
05/5/2024 19:19 | Recency bias plagues many and some deliberately so. Personally I would like it to drop back to 13/14p but that would be for selfish reasons. Do i think it will? I can only see a couple of things in the near term, either some negative news whatever that might entail or a wider market sell off. Gla. | boris cobaka | |
05/5/2024 19:13 | The chart is looking very good here 20's will be hit on Tuesday 30's by Friday A bonus deal signed next week? LOLsss | kryptonsnake | |
05/5/2024 19:01 | Pdt very well put. Things are changing but many can't understand that. I haven't always agreed with ANs methods and voiced plenty of concerns over the years but from about 16 months ago things atarted to change, the concerns I had got addressed one by one. Post the profit warning seeing them at 15p was a bargain and since then the story has gone from strength to strength with multiple revenue streams and products. We are now being signed by huge conpanies and the way the revenue streams work mean going forward they will continue to grow in size and value. At some point it will get taken out as it becomes to important and someone decides to buy it and own the tech and limit their rivals progress. That could see some big numbers depending when it happens but for now happy to see it recovering to more sensible levels.To think this was 40p for years even without fda or any revenue, it's less than half that with fda, increasing revenues and big customers. Kits and assays being developed, Cellkeep etc etc. Roll on next week. | bones698 | |
05/5/2024 18:49 | I was one of those people waiting for the placing before getting back in. Avacta for example fell 50% on its placing recently. However, I decided to Buy after the second Astra announcement and the Proactive interview. Big Pharma know better than me and they have chosen Parsortix clearly for the long game. Phases 2 and 3 and an accompanying diagnostic. Although this will unfold over many years it will be hard for companies to change horses to a competitor solution if one comes along so I feel comfortable with a long hold. However, I suspect they will be bought out long before then. If one or two of those six household names do contract with Angle in the near future the share price will be considerably higher. Raising £10m or so should then be comfortable at a small discount since I suspect they will be attractive to a number of funds now they are around £50m market cap with a Revenue stream stretching into the future. For me the risk/reward balance has changed from waiting for a Placing to buying now and adding if there is a discounted placing. Time will tell but the future looks very exciting and that comes across from the Newland interview on Proactive. It has taken a long time from FDA approval to clear revenue streams appearing but well done to the Angle team. | pdt | |
05/5/2024 18:38 | I like reading the short squirm on a bank holiday weekend.Weekend press has been brilliant. The Times article is a qell deserved shot in the arm, and we all set for 50p | atmysignal | |
05/5/2024 18:34 | Look at all the shorting losers who spent most of their bank holiday weekend on here talking nonsense like it’s going to make a difference 🤡🤡 | paul planet earth 1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions